<table id="table1" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption>Table 1: Pharmacodynamic Dose Response During Opioid/Nitrous Oxide/Oxygen Anesthesia</caption>
<col align="left" valign="middle" width="15%"></col>
<col align="left" valign="middle" width="5%"></col>
<col align="center" valign="middle" width="16%"></col>
<col align="center" valign="middle" width="16%"></col>
<col align="center" valign="middle" width="16%"></col>
<col align="center" valign="middle" width="16%"></col>
<col align="center" valign="middle" width="16%"></col>
<thead>
<tr><th colspan="3" stylecode="Lrule"></th><th colspan="3" stylecode="Botrule">Time to Spontaneous Recovery<footnote id="t1ft2">Values shown are medians of means from individual studies (range of individual patient values).</footnote></th><th stylecode="Botrule Rrule"></th></tr>
<tr><th align="center" colspan="2" stylecode="Lrule">Initial Dose of<br/>mivacurium<footnote>Doses administered over 5 to 15 seconds.</footnote><br/>(mg/kg)</th><th>Time to<br/>Maximum<br/>Block<footnoteref idref="t1ft2"></footnoteref> (min)</th><th>5%<br/>Recovery<br/>(min)</th><th>25%<br/>Recovery<footnote>Clinically effective duration of neuromuscular block.</footnote><br/>(min)</th><th>95%<br/>Recovery<footnote id="t1ft4">Data available for as few as 40% of adults in specific dose groups and for 22% of children in the 0.20 mg/kg dose group due to administration of reversal agents or additional doses of mivacurium prior to 95% recovery or T<sub>4</sub>/T<sub>1</sub> ratio recovery to ≥ 75%.</footnote><br/>(min)</th><th stylecode="Rrule">T<sub>4</sub>/T<sub>1</sub> Ratio<br/>≥75%<footnoteref idref="t1ft4"></footnoteref><br/>(min)</th></tr>
</thead>
<tbody>
<tr><td colspan="7" stylecode="Lrule Rrule"><content stylecode="bold">Adults</content></td></tr>
<tr><td stylecode="Lrule">0.07 to 0.10</td><td>[n=47]</td><td>4.9 (2.0-7.6)</td><td>  11 (7-19)</td><td>  13 (8-24)</td><td>21 (10-36)</td><td stylecode="Rrule">21 (10-36)</td></tr>
<tr><td stylecode="Lrule">0.15</td><td>[n=50]</td><td>3.3 (1.5-8.8)</td><td>  13 (6-31)</td><td>  16 (9-38)</td><td>26 (16-41)</td><td stylecode="Rrule">26 (15-45)</td></tr>
<tr><td stylecode="Lrule">0.20<footnote id="t1ft5">Rapid administration not recommended due to possibility of decreased blood pressure. Administer 0.20 mg/kg over 30 seconds; administer 0.25 mg/kg as divided dose (0.15 mg/kg followed 30 seconds later by 0.10 mg/kg). (See <linkhtml href="#DA">DOSAGE AND ADMINISTRATION</linkhtml>.)</footnote></td><td>[n=50]</td><td>2.5 (1.2-6.0)</td><td>16 (10-29)</td><td>20 (10-36)</td><td>31 (15-51)</td><td stylecode="Rrule">34 (19-56)</td></tr>
<tr stylecode="Botrule"><td stylecode="Lrule">0.25<footnoteref idref="t1ft5"></footnoteref></td><td>[n=48]</td><td>2.3 (1.0-4.8)</td><td>19 (11-29)</td><td>23 (14-38)</td><td>34 (22-64)</td><td stylecode="Rrule">43 (26-75)</td></tr>
<tr><td colspan="7" stylecode="Lrule Rrule"><content stylecode="bold">Children 2 to 12 Years</content></td></tr>
<tr><td stylecode="Lrule">0.11 to 0.12</td><td>[n=17]</td><td>2.8 (1.2-4.6)</td><td>  5 (3-9)</td><td>  7 (4-10)</td><td>-</td><td stylecode="Rrule">-</td></tr>
<tr><td stylecode="Lrule">0.20</td><td>[n=18]</td><td>1.9 (1.3-3.3)</td><td>7 (3-12)</td><td>10 (6-15)</td><td>19 (14-26)</td><td stylecode="Rrule">16 (12-23)</td></tr>
<tr><td stylecode="Lrule">0.25</td><td>[n=  9]</td><td>1.6 (1.0-2.2)</td><td>  7 (4-9)</td><td>  9 (5-12)</td><td>-</td><td stylecode="Rrule">-</td></tr>
</tbody>
</table>